c-Abl: activation and nuclear targets
10.1038/sj.cdd.4400626
Crossref journal-article
Springer Science and Business Media LLC
Cell Death & Differentiation (297)
Bibliography

Shaul, Y. (2000). c-Abl: activation and nuclear targets. Cell Death & Differentiation, 7(1), 10–16.

Authors 1
  1. Y Shaul (first)
References 75 Referenced 111
  1. Van Etten RA . 1999 Cycling, stressed-out and nervous: cellular functions of c-Abl. Trends. Cell Biol. 9: 179–186 (10.1016/S0962-8924(99)01549-4) / Trends. Cell Biol. by RA Van Etten (1999)
  2. Songyang Z, Shoelson SE, McGlade J et al. 1994 Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol. Cell Biol. 14: 2777–2785 (10.1128/MCB.14.4.2777) / Mol. Cell Biol. by Z Songyang (1994)
  3. Cohen GB, Ren R and Baltimore D . 1995 Modular binding domains in signal transduction proteins. Cell 80: 237–248. (10.1016/0092-8674(95)90406-9) / Cell by GB Cohen (1995)
  4. Pawson T . 1994 SH2 and SH3 domains in signal transduction. Adv. Cancer Res. 64: 87–110 (10.1016/S0065-230X(08)60835-0) / Adv. Cancer Res. by T Pawson (1994)
  5. Cicchetti P, Mayer BJ, Thiel G and Baltimore D . 1992 Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. Science 257: 803–806 (10.1126/science.1379745) / Science by P Cicchetti (1992)
  6. Ren R, Mayer BJ, Cicchetti P and Baltimore D . 1993 Identification of a ten-amino acid proline-rich SH3 binding site. Science 259: 1157–1161 (10.1126/science.8438166) / Science by R Ren (1993)
  7. Shi Y, Alin K and Goff SP . 1995 Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity. Genes Dev. 9: 2583–2597 (10.1101/gad.9.21.2583) / Genes Dev. by Y Shi (1995)
  8. Dai Z and Pendergast AM . 1995 Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity. Genes & Dev. 9: 2569–2582 (10.1101/gad.9.21.2569) / Genes & Dev. by Z Dai (1995)
  9. Wen ST and Van Etten RA . 1997 The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. Genes Dev. 11: 2456–2467 (10.1101/gad.11.19.2456) / Genes Dev. by ST Wen (1997)
  10. Shafman T, Khanna KK, Kedar P et al. 1997 Interaction between ATM protein and c-Abl in response to DNA damage. Nature 387: 520–523 (10.1038/387520a0) / Nature by T Shafman (1997)
  11. Baskaran R, Wood LD, Whitaker LL et al. 1997 Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature 387: 516–519 (10.1038/387516a0) / Nature by R Baskaran (1997)
  12. Kharbanda S, Bharti A, Pei D et al. 1996 The stress response to ionizing radiation involves c-Abl-dependent phosphorylation of SHPTP1. Proc. Natl. Acad. Sci. USA 93: 6898–6901 (10.1073/pnas.93.14.6898) / Proc. Natl. Acad. Sci. USA by S Kharbanda (1996)
  13. Agami R and Shaul Y . 1998 The kinase activity of c-Abl but not v-Abl is potentiated by direct interaction with RFXI, a protein that binds the enhancers of several viruses and cell-cycle regulated genes. Oncogene 16: 1779–1788 (10.1038/sj.onc.1201708) / Oncogene by R Agami (1998)
  14. Songyang Z, Shoelson SE, Chaudhuri M et al. 1993 SH2 domains recognize specific phosphopeptide sequences. Cell 72: 767–778 (10.1016/0092-8674(93)90404-E) / Cell by Z Songyang (1993)
  15. Tybulewicz VL, Crawford CE, Jackson PK, Bronson RT and Mulligan RC . 1991 Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65: 1153–1163 (10.1016/0092-8674(91)90011-M) / Cell by VL Tybulewicz (1991)
  16. Schwatzberg PL, Stall AM, Hardin JD et al. 1991 Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell 65: 1165–1175 (10.1016/0092-8674(91)90012-N) / Cell by PL Schwatzberg (1991)
  17. Kipreos ET and Wang JY . 1992 Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA. Science 256: 382–385 (10.1126/science.256.5055.382) / Science by ET Kipreos (1992)
  18. Miao JY and Wang J . 1996 Binding of A/T-rich DNA by three high mobility group-like domains in c-Abl tyrosine kinase. J. Biol. Chem. 271: 22823–22830 (10.1074/jbc.271.37.22823) / J. Biol. Chem. by JY Miao (1996)
  19. McWhirter JR and Wang JY . 19943 An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO J. 12: 1533–1546 (10.1002/j.1460-2075.1993.tb05797.x) / EMBO J. by JR McWhirter (1994)
  20. Van Etten R, Jackson PK, Baltimore D, Sanders MC, Matsudaira PT and Janmey PA . 1994 The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity. J. Cell Biol. 124: 325–340 (10.1083/jcb.124.3.325) / J. Cell Biol. by R Van Etten (1994)
  21. Konopka JB and Witte ON . 1985 Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products. Mol. Cell Biol. 5: 3116–3123 (10.1128/MCB.5.11.3116) / Mol. Cell Biol. by JB Konopka (1985)
  22. Pendergast AM, Muller AJ, Havlik MH, Clark R, McCormick F and Witte ON . 1991 Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor. Proc. Natl. Acad. Sci. USA 88: 5927–5931 (10.1073/pnas.88.13.5927) / Proc. Natl. Acad. Sci. USA by AM Pendergast (1991)
  23. Van Etten R, Jackson P and Baltimore D . 1989 The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization. Cell 58: 669–678 (10.1016/0092-8674(89)90102-5) / Cell by R Van Etten (1989)
  24. Mayer BJ and Baltimore D . 1994 Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase. Mol. Cell Biol. 14: 2883–2894 (10.1128/MCB.14.5.2883) / Mol. Cell Biol. by BJ Mayer (1994)
  25. Welch PJ and Wang JY . 1993 A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 75: 779–790 (10.1016/0092-8674(93)90497-E) / Cell by PJ Welch (1993)
  26. Feller SM, Ren R, Hanafusa H and Baltimore D . 1994 SH2 and SH3 domains as molecular adhesives: the interactions of Crk and Abl. Trends Biochem. Sci. 19: 453–458 (10.1016/0968-0004(94)90129-5) / Trends Biochem. Sci. by SM Feller (1994)
  27. Xu W, Harrision SC and Eck MJ . 1997 Three-dimensional structure of the tyrosine kinase c-Src. Nature 385: 595–602 (10.1038/385595a0) / Nature by W Xu (1997)
  28. Sicheri F, Moarefi I and Kuriyan J . 1997 Crystal structure of the Src family tyrosine kinase Hck. Nature 385: 602–609 (10.1038/385602a0) / Nature by F Sicheri (1997)
  29. Barila D and Superti-Furga G . 1998 An intramolecular SH3-domain interaction regulates c-Abl activity. Nat. Genet. 18: 280–282 (10.1038/ng0398-280) / Nat. Genet. by D Barila (1998)
  30. Kharbanda S, Ren R, Pandey P et al. 1995 Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature 376: 785–788 (10.1038/376785a0) / Nature by S Kharbanda (1995)
  31. Kharbanda S, Pandey P, Jin S et al. 1997 Functional interaction between DNA-PK and c-Abl in response to DNA damage. Nature 386: 732–735 (10.1038/386732a0) / Nature by S Kharbanda (1997)
  32. Nehme A, Baskaran R, Aebi S et al. 1997 Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin. Cancer Res. 57: 3253–3257 / Cancer Res. by A Nehme (1997)
  33. Nehme A, Baskaran R, Nebel S et al. 1999 Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells. Br. J. Cancer 79: 1104–1110 (10.1038/sj.bjc.6690176) / Br. J. Cancer by A Nehme (1999)
  34. David Cordonnier M, Hamdane M, Bailly C and D'Halluin JC . 1998 The DNA binding domain of the human c-Abl tyrosine kinase preferentially binds to DNA sequences containing an AAC motif and to distorted DNA structures. Biochemistry 37: 6065–6076 (10.1021/bi973030w) / Biochemistry by M David Cordonnier (1998)
  35. Dikstein R, Heffetz D, Ben-Neriah Y and Shaul Y . 1992 c-abl has a sequence-specific enhancer binding activity. Cell 69: 751–757 (10.1016/0092-8674(92)90287-M) / Cell by R Dikstein (1992)
  36. Dikstein R, Agami R, Heffetz D and Shaul Y . 1996 p140/c-Abl that binds DNA is preferentially phosphorylated at tyrosine residues. Proc. Natl. Acad. Sci. USA 93: 2387–2391 (10.1073/pnas.93.6.2387) / Proc. Natl. Acad. Sci. USA by R Dikstein (1996)
  37. Reith W, Ucla C, Barras E et al. 1994 RFX1, a transactivator of hepatitis B virus enhancer I, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins. Mol. Cell Biol. 14: 1230–1244 (10.1128/MCB.14.2.1230) / Mol. Cell Biol. by W Reith (1994)
  38. Dikstein R, Faktor O, Ben-Levy R and Shaul Y . 1990 Functional organization of the hepatitis B virus enhancer. Mol. Cell Biol. 10: 3682–3689 / Mol. Cell Biol. by R Dikstein (1990)
  39. Goga A, Liu X, Hambuch TM et al. 1995 p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase. Oncogene 11: 791–799 / Oncogene by A Goga (1995)
  40. Baskaran R, Dahmus ME and Wang JY . 1993 Tyrosine phosphorylation of mammalian RNA polymeraseII carboxyl-terminal domain. Proc. Natl. Acad. Sci. USA 90: 11167–11171 (10.1073/pnas.90.23.11167) / Proc. Natl. Acad. Sci. USA by R Baskaran (1993)
  41. Duyster J, Baskaran R and Wang JY . 1995 Src homology2 domain as a specificity determinant in the c-Abl-mediated tyrosine phosphorylation of the RNA polymeraseII carboxyl-terminal repeated domain. Proc. Natl. Acad. Sci. USA 92: 1555–1559 (10.1073/pnas.92.5.1555) / Proc. Natl. Acad. Sci. USA by J Duyster (1995)
  42. Welch PJ and Wang JY . 1995 Disruption of retinoblastoma protein function by coexpression of its C pocket fragment. Genes & Dev. 9: 31–46 (10.1101/gad.9.1.31) / Genes & Dev. by PJ Welch (1995)
  43. Baskaran R, Escobar SR and Wang JY . 1999 Nuclear c-Abl is a COOH-terminal repeated domain (CTD)-tyrosine (CTD)-tyrosine kinase-specific for the mammalian RNA polymeraseII: possible role in transcription elongation. Cell Growth Differ. 10: 387–396 / Cell Growth Differ. by R Baskaran (1999)
  44. Yuan ZM, Huang Y, Ishiko T et al. 1998 Regulation of Rad51 function by c-Abl in response to DNA damage. J. Biol. Chem. 273: 3799–3802 (10.1074/jbc.273.7.3799) / J. Biol. Chem. by ZM Yuan (1998)
  45. Chen G, Yuan SS, Liu W et al. 1999 Radiation-induced assembly of rad51 and rad52 recombination complex requires ATM and c-Abl. J. Biol. Chem. 274: 12748–12752 (10.1074/jbc.274.18.12748) / J. Biol. Chem. by G Chen (1999)
  46. Chow CS, Barnes CM and Lippard SJ . 1995 A single HMG domain in high mobility group1 protein binds to DNAs as small as 20 base pairs containing the major cisplatin adduct. Biochemistry 34: 2956–2964 (10.1021/bi00009a027) / Biochemistry by CS Chow (1995)
  47. Ohndorf UM, Rould MA, He Q, Pabo CO and Lippard SJ . 1999 Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins. Nature 399: 708–712 (10.1038/21460) / Nature by UM Ohndorf (1999)
  48. Morgan SE and Kastan MB . 1997 p53 and ATM: cell cycle, cell death, and cancer. Adv. Cancer Res. 71: 1–25 (10.1016/S0065-230X(08)60095-0) / Adv. Cancer Res. by SE Morgan (1997)
  49. Yuan ZM, Huang Y, Fan MM, Sawyers C, Kharbanda S and Kufe D . 1996 Genotoxic drugs induce interaction of the c-Abl tyrosine kinase and the tumor suppressor protein p53. J. Biol. Chem. 271: 26457–26460 (10.1074/jbc.271.43.26457) / J. Biol. Chem. by ZM Yuan (1996)
  50. Yuan ZM, Huang Y, Whang Y et al. 1996 Role for c-Abl tyrosine kinase in growth arrest response to DNA damage. Nature 382: 272–274 (10.1038/382272a0) / Nature by ZM Yuan (1996)
  51. Sawyers CL, McLauglin J, Goga A, Havlik M and Witte O . 1994 The nuclear tyrosine kinase c-Abl negatively regulates cell growth. Cell 77: 121–131 (10.1016/0092-8674(94)90240-2) / Cell by CL Sawyers (1994)
  52. Wen ST, Jackson PK and Van Etten RA . 1996 The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products. EMBO J. 15: 1583–1595 (10.1002/j.1460-2075.1996.tb00503.x) / EMBO J. by ST Wen (1996)
  53. Daniel R, Cai Y, Wong PM and Chung SW . 1995 Deregulation of c-abl mediated cell growth after retroviral transfer and expression of antisense sequences. Oncogene 10: 1607–1614 / Oncogene by R Daniel (1995)
  54. Liu ZG, Baskaran R, Lea-Chou ET et al. 1996 Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature 384: 273–276 (10.1038/384273a0) / Nature by ZG Liu (1996)
  55. Koleske AJ, Gifford AM, Scott ML et al. 1998 Essential roles for the Abl and Arg tyrosine kinases in neurulation. Neuron. 21: 1259–1272 (10.1016/S0896-6273(00)80646-7) / Neuron. by AJ Koleske (1998)
  56. Sionov RV, Moallem E, Berger M et al. 1999 c-Abl neutralizes the inhibitory effect of Mdm2 on p53. J. Biol. Chem. 274: 8371–8374 (10.1074/jbc.274.13.8371) / J. Biol. Chem. by RV Sionov (1999)
  57. Agami R, Blandino G, Oren M and Shaul Y . 1999 Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis. Nature 399: 809–813 (10.1038/21697) / Nature by R Agami (1999)
  58. Yuan ZM, Shioya H, Ishiko T et al. 1999 p73 is regulated by tyrosine-kinase c-Abl in the apoptotic response to DNA damage [In Process Citation]. Nature 399: 814–817 (10.1038/21704) / Nature by ZM Yuan (1999)
  59. Zhu J, Jiang J, Zhou W and Chen X . 1998 The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res. 58: 5061–5065 / Cancer Res. by J Zhu (1998)
  60. Knudsen ES and Wang JY . 1996 Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J. Biol. Chem. 271: 8313–8320 (10.1074/jbc.271.14.8313) / J. Biol. Chem. by ES Knudsen (1996)
  61. Welch PJ and Wang JY . 1995 Abrogation of retinoblastoma protein function by c-Abl through tyrosine kinase-dependent and -independent mechanisms. Mol. Cell Biol. 15: 5542–5551 (10.1128/MCB.15.10.5542) / Mol. Cell Biol. by PJ Welch (1995)
  62. Friedberg EC, Bardwell AJ, Bardwell L et al. 1995 Nucleotide excision repair in the yeast Saccharomyces cerevisiae: its relationship to specialized mitotic recombination and RNA polymeraseII basel transcription. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 347: 63–68 (10.1098/rstb.1995.0010) / Philos. Trans. R. Soc. Lond. B. Biol. Sci. by EC Friedberg (1995)
  63. Elledge SJ, Zhou Z, Allen JB and Navas TA . 1993 DNA damage and cell cycle regulation of ribonucleotide reductase. Bioessays 15: 333–339 (10.1002/bies.950150507) / Bioessays by SJ Elledge (1993)
  64. Huang M, Zhou Z and Elledge SJ . 1998 The DNA replication and damage checkpoint pathways induce transcription by inhibition of the Crt1 repressor. Cell 94: 595–605 (10.1016/S0092-8674(00)81601-3) / Cell by M Huang (1998)
  65. Katan Y, Agami R and Shaul Y . 1997 The transcriptional activation and repression domains of RFX1, a context-dependent regulator, can mutually neutralize their activities. Nucleic. Acids Res. 25: 3621–3628 (10.1093/nar/25.18.3621) / Nucleic. Acids Res. by Y Katan (1997)
  66. Dorsch M and Goff SP . 1996 Increased sensitivity to apoptotic stimuli in c-abl-deficient progenitor B-cell lines. Proc. Natl. Acad. Sci. USA 23: 13131–13136 (10.1073/pnas.93.23.13131) / Proc. Natl. Acad. Sci. USA by M Dorsch (1996)
  67. Yuan ZM, Huang Y, Ishiko T, Kharbanda S, Weichselbaum R and Kufe D . 1997 Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase. Proc. Natl. Acad. Sci. USA 94: 1437–1440 (10.1073/pnas.94.4.1437) / Proc. Natl. Acad. Sci. USA by ZM Yuan (1997)
  68. Huang Y, Yuan ZM, Ishiko T et al. 1997 Pro-apoptotic effect of the c-Abl tyrosine kinase in the cellular response to 1-beta-D-arabinofuranosylcytosine. Oncogene 15: 1947–1952 (10.1038/sj.onc.1201376) / Oncogene by Y Huang (1997)
  69. Gong JG, Costanzo A, Yang HQ et al. 1999 The tyrosine-kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399: 806–809 (10.1038/21690) / Nature by JG Gong (1999)
  70. Dan S, Naito M, Seimiya H, Kizaki A, Mashima T and Tsuruo T . 1999 Activation of c-Abl tyrosine kinase requires caspase activation and is not involved in JNK/SAPK activation during apoptosis of human monocytic leukemia U937 cells. Oncogene 18: 1277–1283 (10.1038/sj.onc.1202423) / Oncogene by S Dan (1999)
  71. Kaghad M, Bonnet H, Yang A et al. 1997 Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90: 809–819 (10.1016/S0092-8674(00)80540-1) / Cell by M Kaghad (1997)
  72. Jost CA, Marin MC and Kaelin WJ . 1997 p73 is a human p53-related protein that can induce apoptosis. Nature 389: 191–194 (10.1038/38298) / Nature by CA Jost (1997)
  73. Levine AJ . 1997 p53, the cellular gatekeeper for growth and division. Cell 88: 323–331 (10.1016/S0092-8674(00)81871-1) / Cell by AJ Levine (1997)
  74. Venot C, Maratrat M, Dureuil C, Conseiller E, Bracco L and Debussche L . 1998 The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression. EMBO J. 17: 4668–4679 (10.1093/emboj/17.16.4668) / EMBO J. by C Venot (1998)
  75. Schonthal A, Alberts AS, Frost JA and Feramisco JR . 1991 Differential regulation of jun family gene expression by the tumor promoter okadaic acid. New Biol. 3: 977–986 / New Biol. by A Schonthal (1991)
Dates
Type When
Created 22 years, 11 months ago (Sept. 4, 2002, 12:01 p.m.)
Deposited 2 years, 3 months ago (May 17, 2023, 8:14 p.m.)
Indexed 1 month ago (July 23, 2025, 8:15 a.m.)
Issued 25 years, 7 months ago (Jan. 1, 2000)
Published 25 years, 7 months ago (Jan. 1, 2000)
Published Online 25 years, 5 months ago (March 6, 2000)
Published Print 25 years, 7 months ago (Jan. 1, 2000)
Funders 0

None

@article{Shaul_2000, title={c-Abl: activation and nuclear targets}, volume={7}, ISSN={1476-5403}, url={http://dx.doi.org/10.1038/sj.cdd.4400626}, DOI={10.1038/sj.cdd.4400626}, number={1}, journal={Cell Death & Differentiation}, publisher={Springer Science and Business Media LLC}, author={Shaul, Y}, year={2000}, month=jan, pages={10–16} }